Milestone Pharmaceuticals Inc Net Income per Employee (MIST), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Milestone Pharmaceuticals Inc   (NASDAQ: MIST)
 

Milestone Pharmaceuticals Inc Net Income per Employee

MIST's Quarterly Results, Trends, Rankings, Statistics
Milestone Pharmaceuticals Inc recorded a cumulative net loss of $-84 million during 12 month ending in the second quarter 2026.
The Healthcare sector has seen employees of 323 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 3989, from total ranking in previous quarter at 4600.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MIST Net Income per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -2,210,816 -1,799,026 -1,659,421 -1,526,632 -1,461,289
MIST's Total Ranking # 3989 # 4600 # 4101 # 4153 # 4165
Seq. Net Income Change - - - - -

MIST Company Profile >> Back to MIST Efficiency Comparisons >> Compare MIST Net Income per Employee to its Competitors

MIST Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 324
Healthcare Sector # 755
Overall Market # 3989

Net Income per Employee Statistics
High Average Low
$ -337,658 $ -1,397,990 $ -2,210,816
(Sep 30 2019)   (Jun 30 2026)




  News about Milestone Pharmaceuticals Inc Income per employee

Milestone Pharmaceuticals Sets Sail for Advancement: A Public Offering of Common Shares and Pre-Funded Warrants

Milestone Pharmaceuticals Inc. Commences Public Offering of Common Shares and Pre-Funded Warrants
Milestone Pharmaceuticals Inc. has recently announced the commencement of an underwritten public offering, featuring the sale of its common shares as well as pre-funded warrants for the purchase of common shares. The biopharmaceutical company, renowned for its cardiovascular medicines, will also grant the underwriters an option to acquire additional common shares. This announcement comes in the wake of Milestone Pharmaceuticals Inc. s consistent net losses over the past year.
The objective of this public offering is to raise funds for the development and commercialization of innovative cardiovascular medicines. Milestone Pharmaceuticals Inc. hopes to capitalize on the potential market and investor interest to support their strategic growth plans.




Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2026Number of Employees Jun 30 2026


Date modified: 2026-09-04T10:29:50+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.